CDEK
← All organizations

Tempest Therapeutics

For profitWebsite ↗

Also known as: Tempest Therapeutics

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 20, 2019

Last known activity

Mar 29, 2025

Timeline

2010s

  1. Jun 1, 2011

    Tempest Therapeutics— Founded

2020s

  1. Mar 29, 2021

    Millendo Therapeutics, Inc.— Acquired

Drugs by trial phase (12 distinct, 10 trials)

Phase 3 (3 own, 1 via acquisition)

Phase 2 (0 own, 3 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 3 total across the full acquisition tree)

Recent trials (5)

Details

Founded
San Francisco, CA, US Jun 1, 2011
Last known activity
Mar 29, 2025